Burns Katherine A, Li Yin, Liu Liwen, Korach Kenneth S
Receptor Biology (K.A.B., Y.L., K.S.K.), Laboratory of Reproductive and Developmental Toxicology and Molecular Genomics Core Facility (L.L.), National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina 27709.
Mol Endocrinol. 2014 Aug;28(8):1352-61. doi: 10.1210/me.2014-1122. Epub 2014 Jun 20.
We showed previously that the hinge region of estrogen receptor (ER) α is involved in mediating its actions. The hinge 1 (H1) ERα mutant has disrupted nuclear localization and has lost interaction with c-JUN, but retains estrogen response element (ERE)-mediated functions. The hinge 2 + nuclear export sequence (H2NES) ERα mutant does not maintain nuclear translocation with hormone and no longer activates ERE target genes but does retain a nongenomic, nonnuclear, rapid-action response. Herein, we used the human endometrial cancer Ishikawa stable cell lines (Ishikawa/vector, Ishikawa/wild-type [WT] ERα, Ishikawa/H1 ERα, or Ishikawa/H2NES ERα) to characterize the biological activities of these 2 ERα hinge region mutants. We confirmed by confocal microscopy increased cytoplasmic ERα in the H1 ERα cell line and full cytoplasmic ERα localization in the H2NES ERα cell line. Luciferase assays using the 3xERE reporter showed activation of H1 ERα and H2NES ERα by estradiol (E2) treatment, but using the endogenous pS2 reporter, luciferase activity was only seen with the H1 ERα cell line. Examining cell proliferation revealed that only the WT ERα and H1 ERα cell lines increased proliferation after treatment. Using microarrays, we found that WT ERα and H1 ERα cluster together, whereas vector and H2NES ERα are most similar and cluster independently of E2 treatment. These studies revealed that the nongenomic activities of ERα are unable to mediate proliferative changes or the transcriptional profile after treatment and demonstrate the importance of genomic action for ERα/E2-mediated responses with the nongenomic actions of ERα being complementary to elicit the full biological actions of ERα.
我们之前表明,雌激素受体(ER)α的铰链区参与介导其作用。铰链1(H1)ERα突变体破坏了核定位,失去了与c-JUN的相互作用,但保留了雌激素反应元件(ERE)介导的功能。铰链2 +核输出序列(H2NES)ERα突变体在激素作用下不能维持核转位,不再激活ERE靶基因,但确实保留了一种非基因组、非核的快速作用反应。在此,我们使用人子宫内膜癌Ishikawa稳定细胞系(Ishikawa/载体、Ishikawa/野生型[WT] ERα、Ishikawa/H1 ERα或Ishikawa/H2NES ERα)来表征这两种ERα铰链区突变体的生物学活性。我们通过共聚焦显微镜证实,H1 ERα细胞系中ERα在细胞质中的含量增加,而H2NES ERα细胞系中ERα完全定位于细胞质中。使用3xERE报告基因的荧光素酶测定显示,经雌二醇(E2)处理后H1 ERα和H2NES ERα被激活,但使用内源性pS2报告基因时,仅在H1 ERα细胞系中观察到荧光素酶活性。检测细胞增殖发现,只有WT ERα和H1 ERα细胞系在处理后增殖增加。使用微阵列,我们发现WT ERα和H1 ERα聚集在一起,而载体和H2NES ERα最相似,且与E2处理无关而独立聚集。这些研究表明,ERα的非基因组活性无法介导处理后的增殖变化或转录谱,并证明了基因组作用对于ERα/E2介导的反应的重要性,而ERα的非基因组作用是引发ERα完整生物学作用的补充。